CERC Asia (Cardiovascular European Research Center Asia)

CERC Asia (Cardiovascular European Research Center Asia) is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about CERC Asia (Cardiovascular European Research Center Asia). CERC-Asia is the new Asian subsidiary of CERC, a reputable high-quality dedicated CRO in Europe founded by KOL in Interventional Cardiovascular medicine. Since 2008 CERC-Europe has achieved an excellent track record in regulatory guidance, trial design, strategic planning, global study management and monitoring, biometry, CEC/DSMB coordination, AE/SAE management, core-lab activities (ECG, Angio, IVUS, OCT, CT, MRI) and provides support for communication and publications in major congresses and journals. Over the past few years CERC-Europe has already successfully supported and conducted clinical trials in Asia. Driven by CERC’s wide experience in cardiovascular research and by its passion for human research CERC-Asia has been conceived with the purpose of underpinning the development of cardiovascular clinical research in Asia. Its objectives are to provide better guidance and logistical support in conducting clinical trials, act as a local dedicated CRO and support industry trials.